Dec. 14, 2006 – It will be sold from Sanofi-Aventis under the denomination trades them Acomplia that begins in 2006. Rimonabant could also have been effective as drug anti-addictive in the treatment of alcoholism therefore as added of the stimulant and the nicotine. Rimonabant is an antagonist of the receiver of cannabinoid the CB1.
For more info visit : http://acomplia.blog.co.uk
— End —